163 related articles for article (PubMed ID: 24444546)
21. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.
Zhang L; Wang H; Xu J; Zhu J; Ding K
Toxicol Lett; 2014 Aug; 228(3):248-59. PubMed ID: 24875536
[TBL] [Abstract][Full Text] [Related]
22. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in GH3 cells.
Zhang X; Xu W; Su J; Chu M; Jin H; Li G; Tan C; Wang X; Wang C
Int J Mol Med; 2014 Apr; 33(4):987-93. PubMed ID: 24534837
[TBL] [Abstract][Full Text] [Related]
23. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
24. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effect of brain-derived neurotrophic factor mediated by autophagy through the PI3K/Akt/mTOR pathway.
Chen A; Xiong LJ; Tong Y; Mao M
Mol Med Rep; 2013 Oct; 8(4):1011-6. PubMed ID: 23942837
[TBL] [Abstract][Full Text] [Related]
26. Galangin inhibits proliferation of HepG2 cells by activating AMPK via increasing the AMP/TAN ratio in a LKB1-independent manner.
Zhang H; Li N; Wu J; Su L; Chen X; Lin B; Luo H
Eur J Pharmacol; 2013 Oct; 718(1-3):235-44. PubMed ID: 24028940
[TBL] [Abstract][Full Text] [Related]
27. Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy.
Chen Y; Lv L; Pi H; Qin W; Chen J; Guo D; Lin J; Chi X; Jiang Z; Yang H; Jiang Y
Oncotarget; 2016 Nov; 7(47):76508-76522. PubMed ID: 27793014
[TBL] [Abstract][Full Text] [Related]
28. Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway.
Zhou MQ; Shao L; Wu J; Peng N; Jin LP; Wei GZ; Cheng W; Deng CJ
Mol Med Rep; 2017 Dec; 16(6):8983-8988. PubMed ID: 29039483
[TBL] [Abstract][Full Text] [Related]
29. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
30. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.
Fan TF; Wu TF; Bu LL; Ma SR; Li YC; Mao L; Sun ZJ; Zhang WF
Oncotarget; 2016 Sep; 7(37):59691-59703. PubMed ID: 27474168
[TBL] [Abstract][Full Text] [Related]
31. Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating miR-155-5p/PTEN signaling in diabetic nephropathy.
Guo L; Tan K; Luo Q; Bai X
Bosn J Basic Med Sci; 2020 Aug; 20(3):372-380. PubMed ID: 31668144
[TBL] [Abstract][Full Text] [Related]
32. CCT128930 induces cell cycle arrest, DNA damage, and autophagy independent of Akt inhibition.
Wang FZ; Chang ZY; Fei HR; Yang MF; Yang XY; Sun BL
Biochimie; 2014 Aug; 103():118-25. PubMed ID: 24793486
[TBL] [Abstract][Full Text] [Related]
33. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
34. Dihydromyricetin inhibits Hepatitis B virus replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15 cells.
Wang X; Hu H; Hu B; Xia H; Cheng X; Zheng J; Zhang Z; Liu H
Mol Biol Rep; 2023 Feb; 50(2):1403-1414. PubMed ID: 36474061
[TBL] [Abstract][Full Text] [Related]
35. Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinoma.
Li F; Ma Z; Guan Z; Chen Y; Wu K; Guo P; Wang X; He D; Zeng J
Int J Mol Sci; 2015 Apr; 16(4):8415-29. PubMed ID: 25884331
[TBL] [Abstract][Full Text] [Related]
36. Autophagic cell death induced by resveratrol depends on the Ca(2+)/AMPK/mTOR pathway in A549 cells.
Zhang J; Chiu J; Zhang H; Qi T; Tang Q; Ma K; Lu H; Li G
Biochem Pharmacol; 2013 Jul; 86(2):317-28. PubMed ID: 23680031
[TBL] [Abstract][Full Text] [Related]
37. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
38. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.
Tong X; Smith KA; Pelling JC
Mol Carcinog; 2012 Mar; 51(3):268-79. PubMed ID: 21538580
[TBL] [Abstract][Full Text] [Related]
39. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
